Atypical presentation of an elderly male with autoimmune encephalitis: anti-LG1 limbic encephalitis.
Limbic encephalitis
anti-LG1 encephalitis
autoimmune encephalitis
Journal
Journal of community hospital internal medicine perspectives
ISSN: 2000-9666
Titre abrégé: J Community Hosp Intern Med Perspect
Pays: United States
ID NLM: 101601396
Informations de publication
Date de publication:
02 Aug 2020
02 Aug 2020
Historique:
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
We present a case of an elderly male with anti-LG1 limbic encephalitis involving hypothalamus presenting with acute changes in mental status and persistent hyperthermia. A 74-year-old male presented to the hospital with fever and chills. He had also been evaluated by his PCP for changes in his mental status, trouble remembering things, and following directions while driving. A lumbar puncture was performed, and empiric meningitis coverage was initiated. His LP results were not suggestive for any infectious process. An MRI showed bilateral hippocampal edema. As an infectious workup was non-revealing and other causes were ruled out, with the concern for paraneoplastic or autoimmune encephalitis, patient was started on high dose steroids and plasma exchange while results of antibodies for autoimmune and paraneoplastic encephalitis were awaited. After plasmapheresis and a course of steroids, the patient's mental status began to slowly improve. He was discharged from the hospital and on subsequent neurology office visit, his serum autoimmune encephalitis panel returned positive for anti-LGI 1 antibodies. Further management consisted of outpatient rituximab infusion. Diagnosis of limbic encephalitis can be challenging and can present with symptoms of limbic dysfunction. A modest index of suspicion of limbic encephalitis should be kept in adults with altered mental changes. Early recognition and initiation of therapy can be crucial in the management of patients with autoimmune encephalitis and can prevent permanent cognitive impairment and damage.
Identifiants
pubmed: 32850103
doi: 10.1080/20009666.2020.1785160
pii: 1785160
pmc: PMC7427439
doi:
Types de publication
Case Reports
Langues
eng
Pagination
377-379Informations de copyright
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
J Neurol. 2010 Jun;257(6):1035-8
pubmed: 20130897
Neurol Neuroimmunol Neuroinflamm. 2014 Aug 21;1(3):e24
pubmed: 25340077
Cent Eur J Immunol. 2017;42(2):213-217
pubmed: 28860940
Europace. 2012 Aug;14(8):1188-94
pubmed: 22345374
Ann Neurol. 2011 May;69(5):892-900
pubmed: 21416487
Arq Neuropsiquiatr. 2012 Oct;70(10):817-22
pubmed: 23060110
Lancet Neurol. 2010 Aug;9(8):776-85
pubmed: 20580615
Exp Neurobiol. 2013 Dec;22(4):337-40
pubmed: 24465150